Irradiation Causes Alterations of Polyamine, Purine, and Sulfur Metabolism in Red Blood Cells and Multiple Organs
- PMID: 35043621
- PMCID: PMC8855667
- DOI: 10.1021/acs.jproteome.1c00912
Irradiation Causes Alterations of Polyamine, Purine, and Sulfur Metabolism in Red Blood Cells and Multiple Organs
Abstract
Investigating the metabolic effects of radiation is critical to understand the impact of radiotherapy, space travel, and exposure to environmental radiation. In patients undergoing hemopoietic stem cell transplantation, iron overload is a common risk factor for poor outcomes. However, no studies have interrogated the multiorgan effects of these treatments concurrently. Herein, we use a model that recapitulates transfusional iron overload, a condition often observed in chronically transfused patients. We applied an omics approach to investigate the impact of both the iron load and irradiation on the host metabolome. The results revealed dose-dependent effects of irradiation in the red blood cells, plasma, spleen, and liver energy and redox metabolism. Increases in polyamines and purine salvage metabolites were observed in organs with high oxygen consumption including the heart, kidneys, and brain. Irradiation also impacted the metabolism of the duodenum, colon, and stool, suggesting a potential effect on the microbiome. Iron infusion affected the response to radiation in the organs and blood, especially in erythrocyte polyamines and spleen antioxidant metabolism, and affected glucose, methionine, and glutathione systems and tryptophan metabolism in the liver, stool, and the brain. Together, the results suggest that radiation impacts metabolism on a multiorgan level with a significant interaction of the host iron status.
Keywords: iron; mass spectrometry; metabolism; methionine; organs; polyamine; radiation.
Conflict of interest statement
CONFLICT OF INTEREST
Though unrelated to the contents of this manuscripts, the authors declare that AD is a founder of Omix Technologies Inc.. AD is also a consultant for Altis Biosciences LLC., Rubius Inc. and Forma Inc. AD is a consultant for Hemanext Inc. All the other authors disclose no conflicts of interest relevant to this study.
Figures
References
-
- Fentiman IS; Deshmane V; Tong D; Winter J; Mayles H; Chaudary MA, Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol 2004, 71, (3), 281–5. - PubMed
-
- Henry CJ; Casás-Selves M; Kim J; Zaberezhnyy V; Aghili L; Daniel AE; Jimenez L; Azam T; McNamee EN; Clambey ET; Klawitter J; Serkova NJ; Tan AC; Dinarello CA; DeGregori J, Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J Clin Invest 2015, 125, (12), 4666–80. - PMC - PubMed
-
- Jones CL; Stevens BM; D’Alessandro A; Reisz JA; Culp-Hill R; Nemkov T; Pei S; Khan N; Adane B; Ye H; Krug A; Reinhold D; Smith C; DeGregori J; Pollyea DA; Jordan CT, Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells. Cancer Cell 2018, 34, (5), 724–740.e4. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
